Published in Int J Mol Sci on January 05, 2016
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation. Front Pharmacol (2016) 0.75
Anti-inflammatory and neuroprotective effects of sanguinarine following cerebral ischemia in rats. Exp Ther Med (2016) 0.75
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair. Neurotherapeutics (2016) 0.75
Changes in the cellular immune system and circulating inflammatory markers of stroke patients. Oncotarget (2016) 0.75
Microglia and Monocyte-Derived Macrophages in Stroke. Neurotherapeutics (2016) 0.75
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 13.44
Recognition of microorganisms and activation of the immune response. Nature (2007) 12.99
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (2005) 7.19
Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 6.96
Preventing stroke: saving lives around the world. Lancet Neurol (2007) 6.55
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science (2005) 5.50
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med (2009) 4.87
Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation (2006) 4.61
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol (2010) 4.37
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet (2015) 3.93
Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab (2006) 3.91
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med (2003) 3.89
A new penumbra: transitioning from injury into repair after stroke. Nat Med (2008) 3.59
Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke (2009) 3.55
Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol (2006) 3.28
Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke (2012) 2.88
Medical complications after stroke: a multicenter study. Stroke (2000) 2.81
T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab (2007) 2.75
Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 2.72
Blocking of α4 integrin does not protect from acute ischemic stroke in mice. Stroke (2014) 2.71
Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci (2007) 2.69
Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol (2009) 2.55
Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science (2011) 2.44
Medical complications after stroke. Lancet Neurol (2010) 2.42
Complications and outcome after acute stroke. Does dysphagia matter? Stroke (1996) 2.40
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One (2008) 2.39
Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol (2004) 2.30
Post-stroke infection: a systematic review and meta-analysis. BMC Neurol (2011) 2.29
Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta (2009) 2.21
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood (2010) 2.17
Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med (2004) 2.16
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study. Stroke (2015) 2.06
Control of adaptive immunity by the innate immune system. Nat Immunol (2015) 2.04
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol (2003) 1.97
Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain (2011) 1.95
Autoimmune responses to the brain after stroke are associated with worse outcome. Stroke (2011) 1.95
Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation (2008) 1.92
Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke (2005) 1.91
Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci (2012) 1.89
Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol (2013) 1.87
Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol (2012) 1.84
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab (2000) 1.74
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation. Stroke (2006) 1.74
Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med (2010) 1.69
Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood (2012) 1.64
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med (2009) 1.63
Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci (2011) 1.63
Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab (2005) 1.63
Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol (2010) 1.62
Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke (2007) 1.50
Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. PLoS One (2015) 1.49
Leukocyte recruitment and ischemic brain injury. Neuromolecular Med (2009) 1.47
The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke (2005) 1.44
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis (2007) 1.42
Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol (2007) 1.40
Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40
Cause-specific mortality after first cerebral infarction: a population-based study. Stroke (2003) 1.39
Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke (2006) 1.39
Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology (2012) 1.38
Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis. J Neuroimmunol (2002) 1.36
NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury. Front Immunol (2012) 1.33
Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation (2011) 1.32
Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2009) 1.29
N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke (2013) 1.24
A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab (2009) 1.22
Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry (2006) 1.21
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke (2003) 1.21
Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J Cereb Blood Flow Metab (2012) 1.20
In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J Cereb Blood Flow Metab (2003) 1.17
Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci (2006) 1.16
Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A (2014) 1.16
Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke (2004) 1.14
DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci (2015) 1.12
Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol (2011) 1.11
Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke. BMC Neurosci (2005) 1.11
A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res (2012) 1.10
Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One (2010) 1.10
Essential role of interleukin-6 in post-stroke angiogenesis. Brain (2012) 1.09
Brain-derived antigens in lymphoid tissue of patients with acute stroke. J Immunol (2012) 1.09
Immune responses after acute ischemic stroke or myocardial infarction. Int J Cardiol (2010) 1.08
Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry (2004) 1.08
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke (2005) 1.06
Novel preventive and therapuetic strategy for post-stroke pneumonia. Expert Rev Neurother (2009) 1.00
Neurohormonal activation in ischemic stroke: effects of acute phase disturbances on long-term mortality. Curr Neurovasc Res (2007) 0.99
Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab (2013) 0.99
Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis (2005) 0.98
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol (2013) 0.98
Mortality and cost of pneumonia after stroke for different risk groups. J Stroke Cerebrovasc Dis (2010) 0.98
Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int (2012) 0.97
Toll-like receptor 2 deficiency leads to delayed exacerbation of ischemic injury. J Neuroinflammation (2012) 0.96
Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model. Stroke (2013) 0.96
T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke. Clin Exp Immunol (2008) 0.96
Impact of an immune modulator fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S A (2014) 0.95